Authors' Reply to Ravi Jandhyala's Comment on "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments".

McGettigan, Patricia; Olmo, Carla Alonso; Plueschke, Kelly; Castillon, Mireia; Zondag, Daniel; Bahri, Priya; Kurz, Xavier; Mol, Peter G M

McGettigan, Patricia; Olmo, Carla Alonso; Plueschke, Kelly; Castillon, Mireia; Zondag, Daniel; Bahri, Priya; Kurz, Xavier; Mol, Peter G M.

Affiliation

McGettigan P; William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, UK. p.mcgettigan@qmul.ac.uk.
Olmo CA; Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands.
Plueschke K; Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands.
Castillon M; Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands.
Zondag D; Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands.
Bahri P; Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands.
Kurz X; Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands.
Mol PGM; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.

Drug Saf ; 42(12): 1517-1518, 2019 12.

Article in En | MEDLINE | ID: mdl-31552604

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Limits: Humans Language: En Journal: Drug Saf Journal subject: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Year: 2019 Document type: Article Affiliation country: Reino Unido Country of publication: Nueva Zelanda

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google